21 active trials 13 recruiting 1 Phase 3 5 disease areas
| Phase 1 | 9 | |
| Phase 1/2 | 2 | |
| Phase 2 | 8 | |
| Phase 3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT05804045 | Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER) | Tenosynovial Giant Cell Tumor | Active, Not Recruiting | 2026-05-04 |
| Phase 2 | ||||
| NCT07164170 | A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Glecirasib | Non-Small Cell Lung Cancer | Recruiting | 2026-06-17 |
| NCT07327034 | ABSK-011+BSC vs. Placebo+BSC in Previously Treated Advanced HCC With FGF19 Overexpression | Hepatocellular Carcinoma (HCC) | Recruiting | 2026-01-08 |
| NCT06668103 | A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Firmonertinib | Non-Small Cell Lung Cancer With EGFR Mutation | Recruiting | 2024-12-12 |
| NCT06632262 | A Phase 2 Clinical Study of ABSK061 and ABSK043 | HER2-Gastric/Gastroesophageal Junction Cancer | Recruiting | 2024-11-19 |
| NCT06111274 | A Phase 2 Study of ABSK021 in Patients With Advanced Pancreatic Cancer | Advanced Pancreatic Cancer | Recruiting | 2024-04-11 |
| NCT07710612 | A Phase 2 Study of ABSK043 Combined With Osimertinib | Non-Small Cell Lung Cancer With EGFR-mutated and PD-L1 Positive | Not Yet Recruiting | 2026-07-17 |
| NCT05441475 | A Phase 2, Open-Label Study of ABSK-011 Combined Atezolizumab or SOC in HCC Patients | Hepatocellular Carcinoma | Enrolling by Invitation | 2026-02-25 |
| NCT06186804 | A Phase II Study Evaluating the Efficacy and Safety of ABSK021 (Pimicotinib)) in the… | cGvHD | Enrolling by Invitation | 2024-08-12 |
| Phase 1/2 | ||||
| NCT07417189 | A Phase I/II Study of ABSK141 in Patients With Advanced Solid Tumors ( ABSK141-101 ) | Solid Tumors, Adult | Recruiting | 2026-03-11 |
| NCT07297875 | A Study of ABSK061 to Assess Safety, Tolerability, Pharmacokinetics, and Efficacy in… | Achondroplasia | Not Yet Recruiting | 2025-12-22 |
| Phase 1 | ||||
| NCT07718165 | A Phase I Study of ABSK211 in Participants With Advanced Solid Tumors With KRAS Alteration | Solid Tumor (Phase I) | Recruiting | 2026-09-04 |
| NCT07700953 | A Study to Evaluate the Effects of Low-Fat Meal, High-Fat Meal and Omeprazole… | Healthy Participants | Recruiting | 2026-07-27 |
| NCT04906434 | A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients… | Advanced Liver Cancer | Recruiting | 2026-04-07 |
| NCT04192344 | A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients… | Neoplasms | Recruiting | 2026-03-19 |
| NCT07288957 | A Early Study of ABSK131 in Patients With Advanced/Metastatic Solid Tumors | Solid Tumors (Phase 1) | Recruiting | 2025-12-17 |
| NCT06225804 | A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK112 in Patients With… | Non-Small Cell Lung Cancer | Recruiting | 2024-03-18 |
| NCT05627063 | A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK121-NX in Patients… | Solid Tumor | Active, Not Recruiting | 2025-10-20 |
| NCT06884072 | A Study to Evaluate the Effect of a High-fat Meal on the Exposure of Pimicotinib Capsule… | Healthy Subjects | Active, Not Recruiting | 2025-04-20 |
| NCT06896760 | A Mass Balance Study of [14C]ABSK011 | Healthy Subjects | Not Yet Recruiting | 2025-03-26 |
| Not specified | ||||
| NCT07301463 | A Study in Children With Achondroplasia | Achondroplasia | Recruiting | 2025-12-24 |
Lung Cancer (5) · Non-Small Cell Lung Cancer (NSCLC) (5) · Liver Cancer (3) · Bladder Cancer (1) · Pancreatic Cancer (1)